CClinicalTrials.gg
Active, not recruitingNCT00368095Updated May 6, 2022

Rajavithi Health Promotion Project (Population Base Cohort)

An observational study in Diabetes Mellitus, Hypertension and Dyslipidemia, sponsored by Rajavithi Hospital. Active, not recruiting at 1 site in Thailand. Open to participants aged 16 Years to 120 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-06.

Sponsored by Rajavithi Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
16 Years to 120 Years
Sex
All
01

Study summary

Metabolic Syndrome (hypertension, diabetes mellitus, obesity, cerebrovascular-cardiovascular disease) In Community Survey was performed in central Bangkok.

Prospective Cohort and intensive educated intervention (health promotion program in specific high risk groups) were performed. The aim of the study is to identify high risk patients who can develop serious complications from metabolic syndrome. An analysis of health outcomes in multiple dimensions will be performed.

02

Conditions studied

  • Diabetes Mellitus
  • Hypertension
  • Dyslipidemia
  • Obesity
  • Cardiovascular Disease
  • Coronary Artery Disease

Keywords

  • DM
  • HT
  • Dyslipidemia
  • Obesity
  • Cardiovascular disease
  • Cerebrovascular disease
  • Myocardial infarction
  • stroke
  • Metabolic syndrome
  • CVD-CAD
03

Who can participate

Ages eligible
16 Years to 120 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

General population in Dindang destrict Bangkok

Eligibility criteria

Inclusion Criteria:

  • Age 16 years or more
  • Informed consent
  • Living in selected community (Health Promotion area of Rajavithi Hospital)
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Biospecimen retention
Samples with dna

Interventions

  • BehavioralIntensive Education for Metabolic Syndrome Patients

    Excercise, Intensive diatary program

    Also known as: Patient with Metabolic Syndrome will be advised fro improve health status and genetic test will be apply

05

Study locations

1 site
  • Rajavithi Hospital
    Bangkok, Thailand
06

Registry details

Key details

Study ID
NCT00368095
Lead sponsor
Rajavithi Hospital
Collaborators
U.S. Department of Education
Responsible party
Sponsor
First posted
Aug 24, 2006
Start date
Aug 2006
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 6, 2022

Study contacts

Subsai Kongsaengdao
principal investigator · Rajavithi Hospital
Piyathida Harnsomboonrana, M.D.
study director · Rajavithi Hospital
Wilai Pauvilai, M.D.
study chair · Rajavithi Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion